Mogelijk gemaakt door Google TranslateTranslate
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Latest Press Releases
View all
TimeHeadline
Just nowPress Release Apr 29 2026
29m agoColgate, in partnership with Hong Kong Dental Association, launches TOTAL Periodontal Health Lab
55m agoNavios Maritime Partners L.P. Announces First Day of Trading of Bonds at Euronext Oslo Børs
56m agoAddex GABAB PAM Candidate Demonstrates Solid Anti-Tussive Activity in Bleomycin IPF-Related Chronic Cough Model
56m agoFiverr Announces First Quarter 2026 Results

Innocare Pharma Ltd. A

About

Innocare Pharma Ltd. A (SHG:688428) — investor relations, events, news, and company updates on 6ix.

Latest News

Today
InnoCare Announces First Patient Dosed in Phase III Trial of Orelabrutinib for SLE
Apr 23 2026
InnoCare Releases 2026 Q1 Results: Strong Revenue Growth and Sustained Profitability
Apr 21 2026
Preclinical Data of Novel B7-H3 ADC ICP-B794 Unveiled at 2026 AACR, Demonstrating Superior Anti-Tumor Activity and Safety
Mar 25 2026
InnoCare Releases 2025 Results and Business Highlights, Achieving First Annual Profit
Mar 16 2026
InnoCare Announces First Healthy Volunteer Dosed in Clinical Trial of Novel VAV1 Degrader ICP-538 in China

Financials

Revenue
CN¥2.37 B
Market Cap
CN¥51.77 B
P/E Ratio
77.32
EPS
0.38

Community Chat

Ask AI

6ix6ix